These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 28942556)
1. Europe has to step up its efforts to produce innovative and safe diabetes technology. Cnop M; Klupa T; Tentolouris N; Novials A; Burcelin R; van Eimeren M Diabetologia; 2017 Dec; 60(12):2532-2533. PubMed ID: 28942556 [No Abstract] [Full Text] [Related]
2. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development? Trevitt S; Simpson S; Wood A J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628 [TBL] [Abstract][Full Text] [Related]
3. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
5. Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Russell SJ Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927 [TBL] [Abstract][Full Text] [Related]
6. Closed loop insulin delivery in diabetes. Battelino T; Omladič JŠ; Phillip M Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293 [TBL] [Abstract][Full Text] [Related]
7. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus). Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655 [TBL] [Abstract][Full Text] [Related]
8. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient. Forlenza GP Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732 [No Abstract] [Full Text] [Related]
9. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus. Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528 [TBL] [Abstract][Full Text] [Related]
10. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E; Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304 [TBL] [Abstract][Full Text] [Related]
14. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
15. The artificial pancreas: current status and future prospects in the management of diabetes. Peyser T; Dassau E; Breton M; Skyler JS Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149 [TBL] [Abstract][Full Text] [Related]
16. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]
17. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions. Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389 [TBL] [Abstract][Full Text] [Related]
18. Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell. Wang Y; Dassau E; Zisser H; Jovanovič L; Doyle FJ Diabetes Technol Ther; 2010 Nov; 12(11):879-87. PubMed ID: 20879966 [TBL] [Abstract][Full Text] [Related]
19. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes. Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176 [TBL] [Abstract][Full Text] [Related]
20. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L; Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]